Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 69

Sort by

Sort Order Select

Journal Articles

Nanopore sequencing-based profiling of circular RNAs in multiple myeloma uncovers circNFATC3 as a promising prognostic biomarker

Maria Papatsirou, Christos Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Tsiakanikas, Christine-Ivy Liacos, Maria Gavriatopoulou, Efstathios Kastritis, Meletios Dimopoulos, Jerome Moreaux, Andreas Scorilas, Evangelos Terpos

Blood (2025) 146 (Supplement 1): 7452.

https://doi.org/10.1182/blood-2025-7452

Published: 2025

Journal Articles

Long non-coding RNA (lncRNA) expression signatures distinguish drug response phenotypes in multiple myeloma cell line models

Konstantina Athanasopoulou, Panagiotis G. Adamopoulos, Ioannis Ntanasis-Stathopoulos, Jerome Moreaux, Andreas Scorilas, Evangelos Terpos, Christos Kontos

Blood (2025) 146 (Supplement 1): 7467.

https://doi.org/10.1182/blood-2025-7467

Published: 2025

Journal Articles

Multi-omics integration reveals therapeutic vulnerabilities and immune microenvironment subtypes in Acute Myeloid Leukemia

Elina Alaterre, Hugues De Boussac, Alboukadel Kassambara, Alizee Steer, Amélie Machura, Julien Aityaya, Ouissem Karmous Gadacha, Matthieu Abouladzé, Caroline Bret, Gaspar Aspas Requena, Ludovic Gabellier, Charles Herbaux, Angélique Bruyer, Jerome Moreaux

Blood (2025) 146 (Supplement 1): 1715.

https://doi.org/10.1182/blood-2025-1715

Published: 2025

Journal Articles

N6-methyladenosine (m6A) RNA modification is required to final plasma cell differentiation

Morgane Thomas, Elvira Garcia De Paco, Matthieu Angles, Caroline Bret, Nicolas Robert, Guilhem Requirand, Charles Herbaux, Aurore Attina, Christophe Hirtz, Giacomo Cavalli, Alexandre David, Jerome Moreaux

Blood (2025) 146 (Supplement 1): 5704.

https://doi.org/10.1182/blood-2025-5704

Published: 2025

Journal Articles

CRISPR-ko screen identifies RARα inhibition as a strategy to increase CD38 expression in multiple myeloma and potentiate anti-CD38 therapy.

Laura Alibert, Sara scaramuzzino, Camille Soun, Guilhem Requirand, Nicolas Robert, Laure Vincent, Charles Herbaux, Guillaume Cartron, Caroline Bret, Sandrine Roulland, Jerome Moreaux, Sara Ovejero

Blood (2025) 146 (Supplement 1): 2146.

https://doi.org/10.1182/blood-2025-2146

Published: 2025

Journal Articles

Epitranscriptomic signatures define prognosis and therapeutic vulnerabilities in large B-cell lymphoma

Caroline Molinaro, Jeanne Loiseau, Andrea Romero, Aurore Attina, Sonia Garcia Llorens, Alexandre David, Christophe Hirtz, Denis Coulomb, Guillaume Cartron, Ludovic Gabellier, Jerome Moreaux, Charles Herbaux

Blood (2025) 146 (Supplement 1): 5312.

https://doi.org/10.1182/blood-2025-5312

Published: 2025

Journal Articles

Dual targeting of EZH2 and DOT1L in DLBCL

Jerome Moreaux

Blood (2025) 145 (16): 1714–1715.

https://doi.org/10.1182/blood.2024027324

Published: 2025

Journal Articles

Circular RNA Profiling Using High-Accuracy Long-Read Nanopore Sequencing of Multiple Myeloma Cell Lines Reveals the Wide Diversity of the Circular Transcriptome

Maria Papatsirou, Christos Kontos, Ioannis Ntanasis-Stathopoulos, Christina Sotiropoulou, Christine-Ivy Liacos, Maria Gavriatopoulou, Margaritis Avgeris, Efstathios Kastritis, Meletios Dimopoulos, Jerome Moreaux, Andreas Scorilas, Evangelos Terpos

Blood (2024) 144 (Supplement 1): 3285.

https://doi.org/10.1182/blood-2024-206812

Published: 2024

Journal Articles

KDM6A controls immunogenicity in MM

Jerome Moreaux

Blood (2024) 144 (14): 1465–1467.

https://doi.org/10.1182/blood.2024026013

Published: 2024

Journal Articles

Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation

Elina Alaterre, Sara Ovejero, Caroline Bret, Laure Dutrieux, Dassou Sika, Raul Fernandez Perez, Marion Espéli, Thierry Fest, Michel Cogné, José Ignacio Martin-Subero, Pierre Milpied, Giacomo Cavalli, Jérôme Moreaux

Blood (2024) 144 (5): 496–509.

https://doi.org/10.1182/blood.2023023237

Published: 2024

Includes: Supplemental data

Journal Articles

Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression

Benoît Tisserand, Caroline Bret, Yassine Al Tabaa, Sylvain Lamure, Xavier Ayrignac, Laura Platon, Patrice Ceballos, Ludovic Gabellier, Jerome Moreaux, Charles Herbaux, Guillaume Cartron, Jean-Jacques Tudesq

Blood (2023) 142 (Supplement 1): 3124.

https://doi.org/10.1182/blood-2023-185520

Published: 2023

Journal Articles

Integrative Single-Cell RNA-Seq and Single-Cell ATAC-Seq Analysis of Human Plasma Cell Differentiation

Elina Alaterre, Sara Ovejero, Marion Espéli, Thierry Fest, Michel Cogné, Pierre Milpied, Giacomo Cavalli, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 86.

https://doi.org/10.1182/blood-2023-181507

Published: 2023

Journal Articles

Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology

Emmanuel Varlet, Elina Alaterre, Morgane Thomas, Hugues De Boussac, Laure Vincent, Guillaume Cartron, Charles Herbaux, Caroline Bret, Laurie Herviou, Anne Marie Martinez, Christophe Hirtz, Aurore Attina, Jerome Vialaret, Giacomo Cavalli, Jerome Moreaux, Sara Ovejero

Blood (2023) 142 (Supplement 1): 1964.

https://doi.org/10.1182/blood-2023-181018

Published: 2023

Journal Articles

Characterization of a New Metabolic Score Correlated with CD38 Cell-Surface Expression and Response to Daratumumab Treatment in Multiple Myeloma

Alizée Steer, Elina Alaterre, Djamila Chamlal, Emmanuel Varlet, Amélie Machura, Alboukadel Kassambara, Guilhem Requirand, Nicolas Robert, Laure Vincent, Charles Herbaux, Hugues De Boussac, Angélique Bruyer, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 1949.

https://doi.org/10.1182/blood-2023-180877

Published: 2023

Journal Articles

Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications

Elina Alaterre, Nicolas Robert, Guilhem Requirand, Amélie Machura, Hugues De Boussac, Laure Vincent, Charles Herbaux, Angélique Bruyer, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 4743.

https://doi.org/10.1182/blood-2023-181767

Published: 2023

Journal Articles

Lipid-Mediated Modulation of DNA Damage Signaling As a Prognostic and Therapeutic Strategy Against Multiple Myeloma

Elvira Garcia De Paco, Caroline Soulet, Guilhem Requirand, Nicolas Robert, Guillaume Cartron, Laure Vincent, Charles Herbaux, Maria Moriel-Carretero, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 3322.

https://doi.org/10.1182/blood-2023-181039

Published: 2023

Journal Articles

Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

Laure Dutrieux, Elle Loughran, Armelle Choquet, Hélène Herault, Antoine Guillemin, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Laure Vincent, Charles Herbaux, Eric Rivals, Alexandre David, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 1924.

https://doi.org/10.1182/blood-2023-184749

Published: 2023

Journal Articles

EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma

Djamila Chemlal, Emmanuel Varlet, Amelie Machura, Guilhem Requirand, Nicolas Robert, Elina Alaterre, Laure Vincent, Charles Herbaux, Giacomo Cavalli, Angélique Bruyer, Hugues De Boussac, Jerome Moreaux

Blood (2022) 140 (Supplement 1): 4220–4221.

https://doi.org/10.1182/blood-2022-163261

Published: 2022

Journal Articles

Development of a Robust BH3 Profiling Toolkit for Precision Medicine in Hematologic Malignancies

Valentin Jacquier, Antoine Guillemin, Sara Ovejero-Merino, Guilhem Requirand, Ouissem Karmous-Gadacha, Laure Dutrieux, Andrea Romero, Alizée Steer, Amelie Machura, Hugues De Boussac, Jerome Moreaux, Charles Herbaux

Blood (2022) 140 (Supplement 1): 10727–10728.

https://doi.org/10.1182/blood-2022-163207

Published: 2022

Journal Articles

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Sara ovejero-Merino, Laura Alibert, Julie Devin, Tatiana Cañeque, Ouissem Karmous Gadacha, Matthieu Abouladze, Guilhem Requirand, Nicolas Robert, Hugues De Boussac, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Jerome Moreaux, Caroline Bret

Blood (2022) 140 (Supplement 1): 6439–6440.

https://doi.org/10.1182/blood-2022-164644

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Nanopore sequencing-based profiling of circular RNAs in multiple myeloma uncovers circNFATC3 as a promising prognostic biomarker

Long non-coding RNA (lncRNA) expression signatures distinguish drug response phenotypes in multiple myeloma cell line models

Multi-omics integration reveals therapeutic vulnerabilities and immune microenvironment subtypes in Acute Myeloid Leukemia

N6-methyladenosine (m6A) RNA modification is required to final plasma cell differentiation

CRISPR-ko screen identifies RARα inhibition as a strategy to increase CD38 expression in multiple myeloma and potentiate anti-CD38 therapy.

Epitranscriptomic signatures define prognosis and therapeutic vulnerabilities in large B-cell lymphoma

Dual targeting of EZH2 and DOT1L in DLBCL

Circular RNA Profiling Using High-Accuracy Long-Read Nanopore Sequencing of Multiple Myeloma Cell Lines Reveals the Wide Diversity of the Circular Transcriptome

KDM6A controls immunogenicity in MM

Integrative single-cell chromatin and transcriptome analysis of human plasma cell differentiation

Early Progressions of Undetermined Significance (EPUS) in the Month Following CAR-T Cells for B-Cell NHL Is Mainly Related to Pseudoprogression

Integrative Single-Cell RNA-Seq and Single-Cell ATAC-Seq Analysis of Human Plasma Cell Differentiation

Epigenetic Modifiers MMSET and EZH2 Physically Interact and Cooperate to Support Multiple Myeloma Pathophysiology

Characterization of a New Metabolic Score Correlated with CD38 Cell-Surface Expression and Response to Daratumumab Treatment in Multiple Myeloma

Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications

Lipid-Mediated Modulation of DNA Damage Signaling As a Prognostic and Therapeutic Strategy Against Multiple Myeloma

Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma

Development of a Robust BH3 Profiling Toolkit for Precision Medicine in Hematologic Malignancies

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only